Abstract | BACKGROUND: METHODS: RESULTS: Both oxcarbazepine (1000-3000 nmol/paw; i.pl.) and clonidine (1.9-7.5 nmol/paw; i.pl.) produced a significant dose-dependent reduction of the paw inflammatory hyperalgesia induced by Con A. Yohimbine (260 and 520 nmol/paw; i.pl.), BRL 44408 (100 and 200 nmol/paw; i.pl.) and MK-912 (10 and 20 nmol/paw; i.pl.) significantly depressed the antihyperalgesic effects of oxcarbazepine (2000 nmol/paw; i.pl.) in a dose-dependent manner. The effects of antagonists were due to local effects since they were not observed after administration into the contralateral hindpaw. Oxcarbazepine and clonidine administered jointly in fixed-dose fractions of the ED(50) (1/4, 1/2, and 3/4) caused significant and dose-dependent reduction of hyperalgesia induced by Con A. Isobolographic analysis revealed an additive antihyperalgesic effect. CONCLUSIONS:
|
Authors | Maja A Tomić, Sonja M Vucković, Radica M Stepanović-Petrović, Nenad D Ugresić, Sonja Lj Paranos, Milica S Prostran, Bogdan Bosković |
Journal | Anesthesia and analgesia
(Anesth Analg)
Vol. 105
Issue 5
Pg. 1474-81, table of contents
(Nov 2007)
ISSN: 1526-7598 [Electronic] United States |
PMID | 17959985
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic alpha-2 Receptor Agonists
- Receptors, Adrenergic, alpha-2
- Carbamazepine
- Clonidine
- Oxcarbazepine
|
Topics |
- Adrenergic alpha-2 Receptor Agonists
- Animals
- Carbamazepine
(analogs & derivatives, pharmacology, therapeutic use)
- Clonidine
(pharmacology, therapeutic use)
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Hyperalgesia
(drug therapy, physiopathology)
- Inflammation
(drug therapy, physiopathology)
- Male
- Oxcarbazepine
- Pain
(drug therapy, physiopathology)
- Rats
- Rats, Wistar
- Receptors, Adrenergic, alpha-2
(physiology)
|